Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
Study sponsor: Aclaris Therapeutics, Inc. · ACRS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-12-06Actual
Enrollment · participants47Actual
Source updated2024-11-27Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.